 Overview rationale thrombolysis acute myocardial infarction Treatment coronary thrombosis thrombolytic agents Clinical trials streptokinase effects thrombolysis mortality rates acute myocardial infarction inconclusive Chazov al Soviet Union intracoronary streptokinase prompt recanalization occluded infarct-related artery DeWood al patients classic Q-wave myocardial infarction total occlusion coronary thrombosis infarct-related artery first hours infarction arteries patients hours infarction observations interest thrombolytic therapy acute myocardial infarction Mortality trials agents recombinant tissue plasminogen activator streptokinase plasminogen streptokinase activator complex early mortality rates patients acute myocardial infarction treatment first hours infarction Benefit patients acute myocardial infarction ST-segment depression whole area study TIMI investigators mortality study patients non-Q-wave myocardial infarction unstable angina rest pain tissue plasminogen activator placebo Results trial future appropriate role thrombolytic therapy acute ischemic transmural myocardial infarction